Latest News
Biocytogen partner NEOK Bio secures FDA IND clearance for cancer therapy candidate
27 March 2026 - Biotechnology company Biocytogen Pharmaceuticals (Beijing) Co Ltd (SSE:688796) (HKEX:02315) announced on Friday that its partner NEOK Bio Inc has received US Food and Drug Administration (FDA) clearance for an investigational new drug...
Samsung Biologics honoured at 2026 CDMO Leadership Awards
27 March 2026 - Samsung Biologics (KRX:207940), a South Korea-based contract development and manufacturing organisation (CDMO), said on Thursday that it received recognition at the 2026 CDMO Leadership Awards presented by Outsourced Pharma and Life S...
Hoth Therapeutics deploys OpenClaw AI platform for drug discovery
27 March 2026 - Clinical-stage biopharmaceutical company Hoth Therapeutics Inc (NASDAQ:HOTH) announced on Thursday that it has deployed OpenClaw, an advanced AI-enabled computational platform designed to accelerate drug discovery, improve data-driven...
Insilico Medicine and Tenacia expand AI-driven R&D collaboration
27 March 2026 - Insilico Medicine (HK:3696), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co Limited, a China-based, commercial-stage biopharmaceutical company focused on...
Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator
27 March 2026 - Japanese pharmaceutical company Eisai Co Ltd (TYO:4523) and US-based oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the European Medicines Agency (EMA) has validated the Marketing Authorisation Application (M...